ARST2531 (NCI CIRB) - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
ARST2531: A Randomized Phase 3 Study to Compare VAC (Higher Cyclophosphamide Dose and Intensity) versus VAC/VI (Lower Cyclophosphamide Dose and Intensity) Plus Maintenance Therapy in Patients with Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma
Principal Investigator
Jessica M. Sun, MD
Pediatric Hematology-Oncology Specialist
Protocol Number
IRB:
PRO00120899
NCT:
NCT07466316
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment